IL17RA and pulmonary fibrosis: By contrast, Lo Re et al. demonstrated that IL-17A was dispensable for the fibrotic response and that silica-induced pulmonary fibrosis was not attenuated upon treatment with anti-IL-17A antibody or in IL-17R- deficient mice (85).